Search liu.se
Search
Showing
1 - 7
of 7
hits
Loading results
Molecular physiology of voltage-gated ion channels
Voltage-gated ion channels are key players in all biological systems where they generate and modulate for instance the nervous impulse and pacemaker activity in the heart and the brain.
News |
07 September 2015
Resin may provide medicine against epilepsy
Sticky resin from conifers contains substances that could relieve or cure epilepsy. Researchers at Linköping University have synthesized and tested 71 substances known as resin acids, of which twelve are prime candidates for new medicines.
Employee
Visa alla
News |
27 December 2018
Drug development – not only in industry
Neuroscientists obtain support from SciLifeLab when working to develop new drugs against epilepsy. The project is the first from Linköping University that has been accepted as a full program for the Drug Discovery and Development Platform (DDD).
News |
08 June 2021
A drug from resin to combat epileptic seizures
New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy. A study published in the journal Epilepsia shows that several of the molecules have antiseizure effects.
News |
06 October 2021
Prize winner: “I realise how debilitating a disease epilepsy is”
Fredrik Elinder, professor in molecular neurobiology, has received the Onkel Adam Award for 2021 for his outstanding research in the Faculty of Medicine and Health Sciences at Linköping University.
News |
14 October 2020
New mechanism affecting nerve impulses discovered
Researchers at LiU have discovered a new mechanism by which substances can open a certain type of ion channel and in this way regulate nerve impulses. The discovery, published in the journal PNAS, may help in the development of future drugs.
News |
27 October 2017
New method to dampen nerve signals
Researchers at LiU have discovered a previously unknown molecular binding site that can influence electrical impulses in nerves. The discovery opens the possibility of designing new types of drugs against conditions such as epilepsy.